ACADIA Pharmaceuticals Earnings
NASDAQ: ACADHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$0.21
ACADIA Pharmaceuticals earnings summary
ACADIA Pharmaceuticals is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $0.21. In its most recent report on Aug 5, 2026 (Q2 2026), ACAD posted EPS of $0.18. Revenue for the quarter was $308.0 million.
Quarterly EPS is up 12.5% from the same quarter a year earlier. Across the last 16 reports, ACAD shares moved an average of 6.9% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
ACAD earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $0.18 | — | -3.3% |
| May 7, 2026 | — | $0.02 | — | -4.5% |
| Feb 26, 2026 | — | $1.61 | — | -9.8% |
| Nov 6, 2025 | — | $0.42 | — | +6.4% |
| Aug 7, 2025 | — | $0.16 | — | +3.0% |
| May 8, 2025 | — | $0.11 | — | +27.6% |
| Feb 27, 2025 | — | $0.86 | — | -10.4% |
| Nov 7, 2024 | — | $0.20 | — | -5.0% |
| Aug 7, 2024 | — | $0.20 | — | -1.5% |
| May 9, 2024 | — | $0.10 | — | -3.0% |
| Feb 28, 2024 | — | $0.28 | — | -2.4% |
| Nov 3, 2023 | — | $-0.40 | — | -7.8% |
| Aug 3, 2023 | — | $0.01 | — | +0.7% |
| May 8, 2023 | — | $-0.27 | — | +13.2% |
| Feb 28, 2023 | — | $-0.26 | — | +0.1% |
| Nov 3, 2022 | — | $-0.17 | — | +11.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.